Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of Nuclear Medicine and ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant ...

There are currently several different FDA approved radiopharmaceuticals being used in both large academic and small practice settings to accurately stage and identify local and metastatic prostate ...

Radionuclide therapy is an increasingly important modality in the treatment of various malignancies, utilising radiopharmaceuticals to deliver targeted cytotoxic radiation to diseased tissues. Central ...

Click on the 'Visit E-Learning Course' button on the top. Sign in with your NUCLEUS account, then click on 'Enrol me' on the bottom. If you do not have a NUCLEUS account, please register here first.